Drug Topics

MARCH 27, 2023

The drug Leniolisib, now with the brand name Joenja, treats APDA, a genetic disorder that impairs the immune system. Its annual list price will be $547,500.

Immunization 469

Immunization FDA 469

PharmaVoice

MARCH 27, 2023

Steve Quake, head of science for the Chan Zuckerberg Initiative, who’s had several “once-in-a-lifetime” ideas, provides advice on how to find inspiration.

130

130

Drug Topics

MARCH 27, 2023

Drug Topics® is joined by Thomas W. Taylor, the owner of Williamsburg Drug, for a conversation about starting an independent pharmacy, maintaining patient relationships, and more.

Independent Pharmacies 247

Independent Pharmacies 247

PharmaVoice

MARCH 27, 2023

As streaming services proliferate, and more TV watchers buy in, there’s a new world of possibilities for DTC pharma marketing.

130

130

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

Drug Topics

MARCH 27, 2023

As a GPO member, how many hours a week do you eat up in purchasing? You can unify purchasing and inventory into one integrated solution with best-in-class automation. It won’t replace your GPO — it works with your system giving you greater visibility, accountability, insight, convenience and efficiency.

247

247

PharmaVoice

MARCH 27, 2023

As the biologics industry approaches its next patent cliff, what is the state of the biosimilars market?

130

130

Fierce Healthcare

MARCH 27, 2023

ViVE 2023: UnitedHealth's new tech exec on how the payer giant is aiming to accelerate transformation pminemyer Mon, 03/27/2023 - 22:48

116

116

Drug Topics

MARCH 27, 2023

Speakers at the 2023 virtual Value-Based Insurance Design Summit discussed government programs and company initiatives to advance health equity, as well as the role of research and advocacy to achieve pharmacoequity.

Insurance 247

Insurance 247

Fierce Healthcare

MARCH 27, 2023

Value-based care enabler Wellvana clinches $84M to expand in existing, new markets agliadkovskaya Mon, 03/27/2023 - 14:48

111

111

Drug Topics

MARCH 27, 2023

Vitamin D supplementation may be an effective and safe adjunctive prophylactic therapy to topiramate for children who experience migraine attacks, showed a study conducted in Saudi Arabia.

247

247

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Fierce Pharma

MARCH 27, 2023

Novo's high-dose Rybelsus win tees up regulatory filings—and new rivalries esagonowsky Mon, 03/27/2023 - 09:19

107

107

Drug Store News

MARCH 27, 2023

The limited-edition cereal features Frosted Flakes and green squares of “Creeper Bit” marshmallows that evoke Minecraft’s pixelated block look.

106

106

STAT

MARCH 27, 2023

The Ohio attorney general filed a lawsuit on Monday accusing three large pharmacy benefit managers of fixing prices for various medicines, the latest effort to scrutinize the controversial companies that occupy a crucial role in pharmaceutical pricing. The lawsuit alleges Humana, Prime Therapeutics, and Cigna — which owns Express Scripts — shared pricing information and other data gathered by a company based in Switzerland to gain an upper hand in negotiations with drug companies f

104

104

Drug Store News

MARCH 27, 2023

Mike Stigers will succeed Joe Sheridan, who announced his retirement last year and will remain with the company through the end of the calendar year.

105

105

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

European Pharmaceutical Review

MARCH 27, 2023

Adults with treatment-resistant major depressive disorder (TRD) treated with SPRAVATO ® ▼ (esketamine nasal spray [NS]) achieved significantly higher remission rates compared to those given quetiapine extended-release (XR), long-term Phase III study data has shown. The results from Janssen’s ESCAPE-TRD Phase IIIb trial presented at the European Congress of Psychiatry (EPA) 2023 indicated that esketamine NS achieved significantly higher remission rates from Week 6 and response rates as early as D

Pharmaceutical Companies 103

Pharmaceutical Companies Pharmaceutical Companies 103

Fierce Pharma

MARCH 27, 2023

BioNTech surprises analysts with low revenue guidance as COVID-19 vaccine demand wavers fkansteiner Mon, 03/27/2023 - 09:35

Vaccines 102

Vaccines 102

STAT

MARCH 27, 2023

Public health workers will soon have a new tool at their disposal to thwart a spreading danger to users of illicit drugs: xylazine test strips. The new testing kits will allow health departments, grassroots harm-reduction groups, and individual drug users to test substances for the presence of xylazine, a sedative often referred to as “tranq.

101

101

Fierce Pharma

MARCH 27, 2023

Duo no more: After M&A spree, Pfizer parts ways with Merck KGaA on Bavencio zbecker Mon, 03/27/2023 - 17:42

102

102

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

STAT

MARCH 27, 2023

This article is excerpted from the latest STAT Report: Treating Depression: a new era of promising Drugs. O n May 8, 1972, a researcher at Eli Lilly in Indianapolis named Jong-Sin Horng tested a compound his team had developed and found it had a curious property.

Compounding 98

Compounding 98

Fierce Healthcare

MARCH 27, 2023

ViVE 2023: Hospitals, health tech companies face shortages in data privacy, security talent.

Hospitals 98

Hospitals 98

STAT

MARCH 27, 2023

DALLAS — Inside Kelly Eakin’s garage in suburban Maryland, two of the world’s smallest wheelchairs gather dust. Just a few years ago, these wheelchairs were in high demand. There was a constant waiting list of eight or nine young children with spinal muscular atrophy, or SMA, a devastating disease that could shorten life and stunt growth so severely many patients couldn’t use the child wheelchairs insurance covered.

Insurance 98

Insurance 98

Hospital Pharmacy Europe

MARCH 27, 2023

Undertaking lifelong endurance exercise gives rise to more risk-prone non-calcified coronary plaques compared to fit and healthy individuals The findings of a prospective study by the Master@Heart Consortium has revealed that participation in lifelong endurance exercise, gives rise to a more unfavourable coronary plaque profile compared to healthy and active non-athletes.

Hospitals 98

Hospitals 98

STAT

MARCH 27, 2023

The Food and Drug Administration will convene a meeting of independent advisers to review a personalized cell therapy for ALS that the agency has previously refused to consider. On Monday, BrainStorm Cell Therapeutics, maker of the experimental ALS treatment called NurOwn, said the FDA had agreed to hold an advisory committee meeting. A date has not been set.

FDA 98

FDA 98

Drug Store News

MARCH 27, 2023

DSN’s Retail Excellence Awards spotlight companies that help consumers treat minor maladies with over-the-counter solutions.

98

98

STAT

MARCH 27, 2023

Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and invigorating, because that oh-so familiar routine of online meetings, phone calls, and deadlines has predictably returned. But you knew this would happen, yes? After all, the world, such as it is, keeps spinning. So why not give it a nudge in a better direction with a piping hot cup of stimulation?

Insurance 98

Insurance FDA 98

Hospital Pharmacy Europe

MARCH 27, 2023

Increased ozone levels within the atmosphere are associated with an greater risk of hospital admission for a range of cardiovascular diseases An increased level of atmospheric ozone has been shown to be associated with a greater risk of hospital admission for a number of adverse cardiovascular events according to the findings of a time-series analysis by Chinese researchers.

Hospitals 98

Hospitals 98

STAT

MARCH 27, 2023

Novartis announced data Monday that could set up one of the biggest marketing battles in cancer. At issue is the market for medicines called CDK 4/6 inhibitors. The first of these drugs, Pfizer’s Ibrance, is a $5-billion-a-year product and one of that company’s top sellers. But it has been losing market share to Eli Lilly’s Verzenio.

98

98

Fierce Pharma

MARCH 27, 2023

Look out, Lilly.

97

97

STAT

MARCH 27, 2023

A recent high-profile paper suggesting that science is becoming dramatically less disruptive set the academic world abuzz. One interpretation of this finding — though by no means the only one — is that the exponential growth of the scientific literature has led researchers to build off older and increasingly narrow slices of the research landscape.

98

98

Fierce Pharma

MARCH 27, 2023

With FDA nod for a Novartis castoff, Pharming is set to market a second rare disease drug kdunleavy Mon, 03/27/2023 - 10:40

FDA 90

FDA 90

BioPharm

MARCH 27, 2023

As the therapeutic landscape grows more complex, so too must the analytical techniques for cleaning validation to ensure the utmost cleanliness is achieved.

86

86

Fierce Pharma

MARCH 27, 2023

In new PD-1 showdown, GSK's Jemperli loses initial edge on Merck's Keytruda aliu Mon, 03/27/2023 - 15:40

84

84

Fierce Healthcare

MARCH 27, 2023

CVS set to close $8B deal for health services company Signify Health rking Mon, 03/27/2023 - 11:14

81

81